tradingkey.logo

Immunoprecise Antibodies Ltd

IPA
詳細チャートを表示
2.070USD
0.0000.00%
終値 02/06, 16:00ET15分遅れの株価
95.54M時価総額
損失額直近12ヶ月PER

Immunoprecise Antibodies Ltd

2.070
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

本日

0.00%

5日間

0.00%

1ヶ月

0.00%

6ヶ月

+9.52%

年初来

0.00%

1年間

+307.48%

詳細チャートを表示

TradingKey 株式スコア

データが不十分なため、株式スコアは利用できません。

Immunoprecise Antibodies Ltd ニュース

最新情報をお待ちください...

財務指標

EPS

会社から関連データがまだ開示されていません。

総売上高

会社から関連データがまだ開示されていません。

Immunoprecise Antibodies Ltdの企業情報

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
企業コードIPA
企業名Immunoprecise Antibodies Ltd
最高経営責任者「CEO」Dr. Jennifer Lynne Bath, Ph.D.
ウェブサイトhttps://www.ipatherapeutics.com/
KeyAI